9
| 3 | 2011
Klinisk Biokemi i Norden
•
Inborn errors of metabolism and biochemical genetics
•
Therapeutic drug monitoring
•
Development of new biomarkers and proteomics
•
Cancer including tumor markers, biorhythms and
changes in cellular intermediary metabolism
•
Molecular diagnostics including next generation
sequencing of plasma DNA, genetics of complex
diseases and clinical practice in the era of whole
genome sequence of an entire population
•
Genetic origin of Icelanders
•
Peptide hormones and prohormones as diagnostic
markers in cardiovascular, inflammatory and neo-
plastic disease
•
Laboratory aspects of sports medicine
•
Pros and cons of immunoassay vs. mass spectrometry
•
Anemia of chronic disorders and iron deficiency
•
Patients´ response to laboratory results and direct
to consumer testing
As of now, more than 40 speakers have confirmed their
attendance. They come from all the Nordic countries,
other European countries, North America and Asia.
Besides symposia on these topics the programwill con-
tain symposia for the Astrup and Eldjarn Prizes. The
scientific committee welcomes suggestions for other
interesting topics to be included in the conference.
Of special interest to the younger members of our
profession, we are privileged to announce that the
journal Clinical Chemistry will have a symposium on
scientific writing. Writing for an internationally lead-
ing journal is a vital skill for ambitious young scientists.
In short, we aim to present the best possible program
at the best possible time of year in Iceland. Now we
need the best possible people to attend. Please join us
in Reykjavík in 2012!
Landmannalaugar, Island. Foto: Ingunn Þorsteinsdóttir.
